Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis

BACKGROUND: Temsirolimus, a selective inhibitor of the mammalian target of rapamycin, has demonstrated clinical benefit versus investigator’s choice (INV) of therapy in patients with relapsed/refractory mantle cell lymphoma (MCL). METHODS: This post hoc study retrospectively assigned simplified Mant...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Exp Hematol Oncol
Asıl Yazarlar: Hess, Georg, Coiffier, Bertrand, Crump, Michael, Gisselbrecht, Christian, Offner, Fritz, Romaguera, Jorge, Kang, Lisa, Moran, Pádraig J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4416347/
https://ncbi.nlm.nih.gov/pubmed/25938001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0006-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller